Received Mar 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Y3ME2 | — |
Administration of expired dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix 720) (batch number Y3ME2, expiry date 25-FEB-2025) for prophylaxis. On 25-FEB-2025, the patient received Havrix 720. On 25-FEB-2025, an unknown time after receiving Havrix 720, the patient experienced expired vaccine used (Verbatim: Administration of expired dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-FEB-2025 The reporter reported that the patient had given expired hep A vaccine just 2 day later from the expiration day which led to expired vaccine used. The reporter had to re-vaccinated the patient or not. This adverse event was received via Webform. No further details provided.